This section provides an overview of, and guidance on, key governance and business integrity topics including: corporate governance, anti-money laundering, anti-corruption, whistleblowing and sanctions.
CDC believes that strengthening governance and business integrity systems helps to improve company performance, reduce long-term costs and increase development impacts.
High quality corporate governance can have a developmental effect by enhancing a company’s reputation, improving internal controls, and ultimately helping it seek commercial backing. Robust business integrity practices help mitigate compliance, reputational, and operational risks, and protect companies from the large fines and jail time can result from unethical behaviour. Fund managers should address these issues in every investment.
For more guidance on how these issues should be addressed by fund managers, please see Fund Governance and Business Integrity Management System.